<DOC>
	<DOC>NCT01939990</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).</brief_summary>
	<brief_title>Safety Study of Nebivolol for COPD Patients</brief_title>
	<detailed_description>The study would be a randomized, placebo-controlled trial of 60 hypertensive patients with documented COPD greater than age 40.</detailed_description>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Clinical diagnosis of high blood pressure and chronic obstructive pulmonary disease (COPD) Asthma; Heart failur; End stage kidney disease; acute myocardial infarction,unstable angina, stroke or TIA within the past year; Females who are pregnant, lactating or women of childbearing potential who are not using approved method of contraception.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
</DOC>